Comparing the Predictivity of Human Placental Gene, microRNA, and CpG Methylation Signatures in Relation to Perinatal Outcomes
Open Access
- 13 July 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 183 (2) , 269-284
Abstract
Molecular signatures are being increasingly integrated into predictive biology applications. However, there are limited studies comparing the overall predictivity of transcriptomic versus epigenomic signatures in relation to perinatal outcomes. This study set out to evaluate mRNA and microRNA (miRNA) expression and cytosine-guanine dinucleotide (CpG) methylation signatures in human placental tissues and relate these to perinatal outcomes known to influence maternal/fetal health; namely, birth weight, placenta weight, placental damage, and placental inflammation. The following hypotheses were tested: (1) different molecular signatures will demonstrate varying levels of predictivity towards perinatal outcomes, and (2) these signatures will show disruptions from an example exposure (ie, cadmium) known to elicit perinatal toxicity. Multi-omic placental profiles from 390 infants in the Extremely Low Gestational Age Newborns cohort were used to develop molecular signatures that predict each perinatal outcome. Epigenomic signatures (ie, miRNA and CpG methylation) consistently demonstrated the highest levels of predictivity, with model performance metrics including R2 (predicted vs observed) values of 0.36–0.57 for continuous outcomes and balanced accuracy values of 0.49–0.77 for categorical outcomes. Top-ranking predictors included miRNAs involved in injury and inflammation. To demonstrate the utility of these predictive signatures in screening of potentially harmful exogenous insults, top-ranking miRNA predictors were analyzed in a separate pregnancy cohort and related to cadmium. Key predictive miRNAs demonstrated altered expression in association with cadmium exposure, including miR-210, known to impact placental cell growth, blood vessel development, and fetal weight. These findings inform future predictive biology applications, where additional benefit will be gained by including epigenetic markers.Keywords
Funding Information
- National Institutes of Health
- NIH (UG3OD023348, UH3OD023348)
- National Institute of Child Health and Human Development (R01HD092374, R03HD101413)
- National Institute of Nursing Research (K23NR017898, R01NR019245)
- National Institute of Environmental Health Sciences (P42ES031007)
- Institute for Environmental Health Solutions
- University of North Carolina Gillings School of Global Public Health
This publication has 76 references indexed in Scilit:
- Low-level processing of Illumina Infinium DNA Methylation BeadArraysNucleic Acids Research, 2013
- GENCODE: The reference human genome annotation for The ENCODE ProjectGenome Research, 2012
- MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm laborProceedings of the National Academy of Sciences, 2012
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- A pharmacogenomic method for individualized prediction of drug sensitivityMolecular Systems Biology, 2011
- Analysis of microRNA turnover in mammalian cells following Dicer1 ablationNucleic Acids Research, 2011
- Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers2010
- A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic LeukemiaClinical Cancer Research, 2009
- Pregnancy Disorders That Lead to Delivery Before the 28th Week of Gestation: An Epidemiologic Approach to ClassificationAmerican Journal of Epidemiology, 2008
- Histological characteristics of singleton placentas delivered before the 28th week of gestationPathology, 2008